Braillon A, Capron J P, Hervé M A, Degott C, Quenum C
Gut. 1985 Feb;26(2):133-9. doi: 10.1136/gut.26.2.133.
We report on clinical, nutritional, and hepatic histological findings in 50 non-selected obese subjects (mean overweight +74%; range +21-138%). The pathogenesis of the liver damage was assessed with the help of multidimensional analysis of a number of clinical variables. According to the severity of the hepatic lesions, the patients have been ranged in five groups: O (normal liver) 10%; I (fatty liver) 48%; II (fatty hepatitis) 26%; III (fatty fibrosis) 8%; IV (fatty cirrhosis) 8%. The more severe changes (groups III and IV) were constantly associated with excessive alcohol intake. The multidimensional analysis was unable to find a relationship between obesity and the development of fibrosis and cirrhosis whereas it showed that: (a) there was a highly significant correlation between the daily ethanol intake and the degree of overweight, (b) severe fatty metamorphosis was significantly associated with the degree of overweight, the existence of diabetes mellitus, and the amount of alcohol and fat intake, (c) nutritional factors, in particular deficient protein intake, have only an accessory effect in the development of mild inflammation and fibrosis, (d) the consumption of potentially hepatotoxic drugs, very high in the obese (about five drugs per day) could have a role in the development of cirrhosis. In conclusion in our study, there was no evidence that obesity per se could result in severe liver damage.
我们报告了50名未经挑选的肥胖受试者的临床、营养和肝脏组织学检查结果(平均超重74%;范围为21%-138%)。借助对多个临床变量的多维度分析评估肝脏损伤的发病机制。根据肝脏病变的严重程度,将患者分为五组:O组(正常肝脏)10%;I组(脂肪肝)48%;II组(脂肪性肝炎)26%;III组(脂肪性纤维化)8%;IV组(脂肪性肝硬化)8%。更严重的病变(III组和IV组)常与过量饮酒有关。多维度分析未能发现肥胖与纤维化和肝硬化的发展之间存在关联,然而其显示:(a)每日乙醇摄入量与超重程度之间存在高度显著的相关性,(b)严重的脂肪变性与超重程度、糖尿病的存在以及酒精和脂肪摄入量显著相关,(c)营养因素,尤其是蛋白质摄入不足,在轻度炎症和纤维化的发展中仅起辅助作用,(d)肥胖者中潜在肝毒性药物的消耗量很高(每天约五种药物)可能在肝硬化的发展中起作用。总之,在我们的研究中,没有证据表明肥胖本身会导致严重的肝脏损伤。